研发-话题@MedSci

#研发#

826篇内容 | 7084人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2021年6月11日全球新冠肺炎疫情及疫苗接种简报：日新增41.6万，全球争相研发第二代新冠疫苗, objectType=article, longId=212604, objectId=dc8721260423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc8721260423, replyNumber=0, likeNumber=67, createdTime=2021-06-12, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc8721260423, moduleTitle=2021年6月11日全球新冠肺炎疫情及疫苗接种简报：日新增41.6万，全球争相研发第二代新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc8721260423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300471, encodeId=e05c13004e1cc, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle= Nat Commun：血液凝固机制的发现对新的抗血栓药物研发有了新进展, objectType=article, longId=212466, objectId=481c21246636, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481c21246636, replyNumber=0, likeNumber=114, createdTime=2021-06-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481c21246636, moduleTitle= Nat Commun：血液凝固机制的发现对新的抗血栓药物研发有了新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=481c21246636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300470, encodeId=d23913004e08c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=研发：中国GMP、GSP认证管理办法废止，沃森生物新冠腺病毒疫苗获批临床, objectType=article, longId=212092, objectId=afbb212092e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afbb212092e3, replyNumber=0, likeNumber=90, createdTime=2021-06-01, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afbb212092e3, moduleTitle=研发：中国GMP、GSP认证管理办法废止，沃森生物新冠腺病毒疫苗获批临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afbb212092e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300469, encodeId=3bd11300469fa, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕, objectType=article, longId=211976, objectId=8fc22119e6c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fc22119e6c8, replyNumber=0, likeNumber=35, createdTime=2021-05-30, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fc22119e6c8, moduleTitle=会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fc22119e6c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300468, encodeId=34781300468af, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2021年5月21日全球新冠肺炎（COVID-19）疫情简报，日新增63.4万，全球开始研发新冠疫苗2.0版，全球重症人数再次降至10万例以内, objectType=article, longId=211610, objectId=0c85211610c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c85211610c7, replyNumber=0, likeNumber=67, createdTime=2021-05-22, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c85211610c7, moduleTitle=2021年5月21日全球新冠肺炎（COVID-19）疫情简报，日新增63.4万，全球开始研发新冠疫苗2.0版，全球重症人数再次降至10万例以内, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c85211610c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300498, encodeId=22b71300498da, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=默沙东中国研发中心十年：守正出奇, objectType=article, longId=211394, objectId=7e6a2113948a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e6a2113948a, replyNumber=0, likeNumber=48, createdTime=2021-05-17, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e6a2113948a, moduleTitle=默沙东中国研发中心十年：守正出奇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e6a2113948a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300467, encodeId=b269130046eec, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Nat Commun：孙锟、饶子和共同研发出新型高亲和力，广谱新冠病毒中和抗体, objectType=article, longId=211376, objectId=063c2113e639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063c2113e639, replyNumber=0, likeNumber=91, createdTime=2021-05-17, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063c2113e639, moduleTitle=Nat Commun：孙锟、饶子和共同研发出新型高亲和力，广谱新冠病毒中和抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063c2113e639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300466, encodeId=09c5130046616, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=辉瑞暂停BCMA/CD3双抗elranatamab的临床试验，BCMA/CD3双特异性抗体是全球研发热点, objectType=article, longId=210832, objectId=8fed21083275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fed21083275, replyNumber=0, likeNumber=62, createdTime=2021-05-06, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fed21083275, moduleTitle=辉瑞暂停BCMA/CD3双抗elranatamab的临床试验，BCMA/CD3双特异性抗体是全球研发热点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fed21083275)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300495, encodeId=1cb713004958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=阿斯利康全球研发中国中心正式开幕，助力上海打造**生物医药产业高地 , objectType=article, longId=210135, objectId=92c82101353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c82101353f, replyNumber=0, likeNumber=57, createdTime=2021-04-20, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c82101353f, moduleTitle=阿斯利康全球研发中国中心正式开幕，助力上海打造**生物医药产业高地 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92c82101353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300465, encodeId=177b130046510, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=CD47单克隆抗体初露锋芒！天镜生物多项研发管线产品齐头并进, objectType=article, longId=209745, objectId=fb33209e4510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb33209e4510, replyNumber=0, likeNumber=54, createdTime=2021-04-11, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb33209e4510, moduleTitle=CD47单克隆抗体初露锋芒！天镜生物多项研发管线产品齐头并进, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb33209e4510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300464, encodeId=5d6d130046465, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=科辉智药获1.5亿元Pre-A轮融资，加速计算化学驱动新药研发, objectType=article, longId=209531, objectId=7ded209531ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ded209531ed, replyNumber=0, likeNumber=31, createdTime=2021-04-05, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ded209531ed, moduleTitle=科辉智药获1.5亿元Pre-A轮融资，加速计算化学驱动新药研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ded209531ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300463, encodeId=02271300463f1, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=东曜药业：深度布局抗肿瘤ADC药物的研发及商业化, objectType=article, longId=209505, objectId=cd5120950549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd5120950549, replyNumber=0, likeNumber=96, createdTime=2021-04-05, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd5120950549, moduleTitle=东曜药业：深度布局抗肿瘤ADC药物的研发及商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd5120950549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300462, encodeId=b8771300462a5, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, objectType=article, longId=209484, objectId=493e20948420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=493e20948420, replyNumber=0, likeNumber=70, createdTime=2021-04-05, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=493e20948420, moduleTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=493e20948420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300461, encodeId=884f13004613e, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, objectType=article, longId=209421, objectId=764820942176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=764820942176, replyNumber=0, likeNumber=65, createdTime=2021-04-05, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=764820942176, moduleTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=764820942176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300460, encodeId=2fb41300460b7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司, objectType=article, longId=209142, objectId=df2420914253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2420914253, replyNumber=0, likeNumber=67, createdTime=2021-03-30, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2420914253, moduleTitle=综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2420914253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300459, encodeId=ac4d1300459c1, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=纽脉医疗完成逾亿美元C轮融资加速结构性心脏病介入产品的研发, objectType=article, longId=209094, objectId=0b0620909452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b0620909452, replyNumber=0, likeNumber=84, createdTime=2021-03-29, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b0620909452, moduleTitle=纽脉医疗完成逾亿美元C轮融资加速结构性心脏病介入产品的研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b0620909452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300458, encodeId=b24d130045817, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Nature：电子皮肤的研发将改变人类的生活和医疗的发展, objectType=article, longId=208988, objectId=e734208988e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e734208988e8, replyNumber=0, likeNumber=50, createdTime=2021-03-27, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e734208988e8, moduleTitle=Nature：电子皮肤的研发将改变人类的生活和医疗的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e734208988e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300457, encodeId=ac0d130045ea3, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=逝者：著名癌症研究者，AZ肿瘤研发负责人JoséBaselga去世，享年61岁, objectType=article, longId=208853, objectId=a56420885340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a56420885340, replyNumber=0, likeNumber=63, createdTime=2021-03-24, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a56420885340, moduleTitle=逝者：著名癌症研究者，AZ肿瘤研发负责人JoséBaselga去世，享年61岁, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a56420885340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300456, encodeId=ab0a1300456ac, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=中国又传好消息！一文回顾争分夺秒的新冠疫苗研发, objectType=article, longId=208600, objectId=7fcd20860047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fcd20860047, replyNumber=0, likeNumber=73, createdTime=2021-03-19, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fcd20860047, moduleTitle=中国又传好消息！一文回顾争分夺秒的新冠疫苗研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fcd20860047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300455, encodeId=a466130045582, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=2.26亿研发费用打水漂，百奥泰终止一项在研ADC项目, objectType=article, longId=208110, objectId=7a02208110ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a02208110ba, replyNumber=0, likeNumber=66, createdTime=2021-03-09, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a02208110ba, moduleTitle=2.26亿研发费用打水漂，百奥泰终止一项在研ADC项目, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a02208110ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

研发

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#研发#

2021年6月11日全球新冠肺炎疫情及疫苗接种简报：日新增41.6万，全球争相研发第二代新冠疫苗

2021-06-12

lqvr (审核中...)

前往app查看评论内容

#研发#

Nat Commun：血液凝固机制的发现对新的抗血栓药物研发有了新进展

2021-06-10

lqvr (审核中...)

前往app查看评论内容

#研发#

研发：中国GMP、GSP认证管理办法废止，沃森生物新冠腺病毒疫苗获批临床

2021-06-01

lqvr (审核中...)

前往app查看评论内容

#研发#

会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕

2021-05-30

lqvr (审核中...)

前往app查看评论内容

#研发#

2021年5月21日全球新冠肺炎（COVID-19）疫情简报，日新增63.4万，全球开始研发新冠疫苗2.0版，全球重症人数再次降至10万例以内

2021-05-22

lqvr (审核中...)

前往app查看评论内容

#研发#

默沙东中国研发中心十年：守正出奇

2021-05-17

lqvr (审核中...)

前往app查看评论内容

#研发#

Nat Commun：孙锟、饶子和共同研发出新型高亲和力，广谱新冠病毒中和抗体

2021-05-17

lqvr (审核中...)

前往app查看评论内容

#研发#

辉瑞暂停BCMA/CD3双抗elranatamab的临床试验，BCMA/CD3双特异性抗体是全球研发热点

2021-05-06

lqvr (审核中...)

前往app查看评论内容

#研发#

阿斯利康全球研发中国中心正式开幕，助力上海打造**生物医药产业高地

2021-04-20

lqvr (审核中...)

前往app查看评论内容

#研发#

CD47单克隆抗体初露锋芒！天镜生物多项研发管线产品齐头并进

2021-04-11

lqvr (审核中...)

前往app查看评论内容

#研发#

科辉智药获1.5亿元Pre-A轮融资，加速计算化学驱动新药研发

2021-04-05

lqvr (审核中...)

前往app查看评论内容

#研发#

东曜药业：深度布局抗肿瘤ADC药物的研发及商业化

2021-04-05

lqvr (审核中...)

前往app查看评论内容

#研发#

国际！中科院研发的这款重组新冠疫苗获批紧急使用

2021-04-05

lqvr (审核中...)

前往app查看评论内容

#研发#

国际！中科院研发的这款重组新冠疫苗获批紧急使用

2021-04-05

lqvr (审核中...)

前往app查看评论内容

#研发#

综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司

2021-03-30

lqvr (审核中...)

前往app查看评论内容

#研发#

纽脉医疗完成逾亿美元C轮融资加速结构性心脏病介入产品的研发

2021-03-29

lqvr (审核中...)

前往app查看评论内容

#研发#

Nature：电子皮肤的研发将改变人类的生活和医疗的发展

2021-03-27

lqvr (审核中...)

前往app查看评论内容

#研发#

逝者：著名癌症研究者，AZ肿瘤研发负责人JoséBaselga去世，享年61岁

2021-03-24

lqvr (审核中...)

前往app查看评论内容

#研发#

中国又传好消息！一文回顾争分夺秒的新冠疫苗研发

2021-03-19

lqvr (审核中...)

前往app查看评论内容

#研发#

2.26亿研发费用打水漂，百奥泰终止一项在研ADC项目

2021-03-09

科室
- - 订阅+
  - 更多科室
工具
服务